© Reuters. Abbott Labs Earnings, Revenue beat in Q4
Investing.com – Abbott Labs (NYSE:) reported on Wednesday fourth quarter that beat analysts’ forecasts and revenue that topped expectations.
Abbott Labs announced earnings per share of $1.45 on revenue of $10.70B. Analysts polled by Investing.com anticipated EPS of $1.35 on revenue of $9.94B.
Abbott Labs shares are down 5% from the beginning of the year and are trading at $117.87 , down-from-52-week-high.They are under-performing the S&P 500 which is up 2.49% from the start of the year.
Abbott Labs shares gained 2.74% in pre-market trade the report.
Abbott Labs follows other major Healthcare sector earnings this month
Abbott Labs’s report follows an earnings beat by J&J on Tuesday, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.83 on revenue of $21.69B.
Novartis ADR had missed expectations on Tuesday with fourth quarter EPS of $1.34 on revenue of $12.77B, compared to forecast for EPS of $1.36 on revenue of $12.92B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.